Multimedia | VHL Regional Portal

Resources found: 20

Coletiva de imprensa: anúncios do Governo SP - 17/12/2020

Date: 17/12/2020

O Governador João Doria anunciou a chegada, nesta quinta-feira (17), de 2 milhões de doses prontas da vacina contra o coronavírus, a Coronavac, desenvolvida em parceria com o Instituto Butantan. Trata-se do maior lote de vacinas que chega à América do Sul até o momento. “A pressa pela vacina é a pressa pela vida. Todos os brasileiros de bem têm pressa. São Paulo, reafirmo aqui, começar...
See more details

Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Brazilian Health Surveillance Agency, Holidays, Epidemiological Monitoring, Clinical Trial, Phase III, Immunization Programs/organization & administration, Public-Private Sector Partnerships/organization & administration, Risk Groups, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Local Health Systems/organization & administration, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Masks, Social Isolation, Schools/standards, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech

Ministério da Saúde apresenta balanço de ações contra a COVID-19

Date: 03/11/2020

Siga o Ministério da Saúde http://www.twitter.com/minsaude http://www.facebook.com/minsaude http://www.instagram.com/minsaude https://www.linkedin.com/company/mini...
See more details

Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/statistics & numerical data, Local Health Systems/organization & administration, Epidemiological Monitoring, Financial Resources in Health/economics, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Ventilators, Mechanical/supply & distribution, Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Personal Protective Equipment/supply & distribution, Primary Health Care/economics, Chloroquine/supply & distribution, Hydroxychloroquine/supply & distribution, Oseltamivir/supply & distribution, Brazil/epidemiology, Health Personnel/organization & administration, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Polymerase Chain Reaction/statistics & numerical data, Viral Vaccines/supply & distribution, Clinical Trial, Phase III, Immunization Programs/organization & administration, Risk Groups, COVID-19, Covax, Vacina de Oxford, Coronavac

Coletiva de imprensa: avanços importantes nos testes clínicos da fase 3 da Coronavac

Date: 23/11/2020

O Governo de São Paulo e o Instituto Butantan confirmaram nesta segunda-feira (23) que o estudo clínico da CoronaVac chegou à fase final e os resultados sairão já na primeira semana de dezembro. A previsão é que 46 milhões de doses estejam disponíveis no Brasil até janeiro de 2021. Isso será possível porque o estudo clínico alcançou o patamar necessário para abertura da pesquisa e a...
See more details

Pneumonia, Viral/prevention & control, Coronavirus Infections/prevention & control, Pandemics/prevention & control, Betacoronavirus/immunology, Viral Vaccines/immunology, Governmental Research Institutes, Clinical Trial, Phase III, Healthy Volunteers, Epidemiological Monitoring, Hospital Bed Capacity/statistics & numerical data, Local Health Systems/organization & administration, Brazilian Health Surveillance Agency, Mass Vaccination, Intensive Care Units/statistics & numerical data, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech, Gorinchteyn, Jean

Coletiva de imprensa: anúncios do Governo SP - 12/11/2020

Date: 12/11/2020

O Governador João Doria anunciou nesta quinta-feira (12) a assinatura de contrato para revitalização da antiga Usina da Traição, firmado entre a Empresa Metropolitana de Águas e Energia S.A. (EMAE) e o consórcio Usina São Paulo SPE S.A. O grupo venceu a licitação realizada em setembro e será responsável por implementar espaços de uso público na área de 29.804 metros quadrados, inclu...
See more details

Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Coronavirus Infections/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/epidemiology, Pneumonia, Viral/immunology, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Epidemiological Monitoring, Local Health Systems/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Brazilian Health Surveillance Agency, Viral Vaccines/supply & distribution, Viral Vaccines/immunology, Clinical Trial, Phase III, Environment, Environmental Restoration and Remediation, Healthy Volunteers, COVID-19, Plano São Paulo, Doria, João, Coronavac, Instituto Butantan, Sinovac Biotech, Novo Rio Pinheiros , Empresa Metropolitana de Águas e Energia S.A., Usina São Paulo SPE S.A

Coletiva de imprensa: anúncios do Governo SP - 05/11/2020

Date: 05/11/2020

Saiba mais em: www.saopaulo.sp.gov.br/coronavirus
See more details

Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Epidemiological Monitoring, Local Health Systems/organization & administration, Intensive Care Units/statistics & numerical data, Hospital Bed Capacity/statistics & numerical data, Quarantine/organization & administration, Masks, Social Isolation, Schools/statistics & numerical data, Organizations/statistics & numerical data, Police, Viral Vaccines/immunology, Healthy Volunteers, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Clinical Trial, Phase III, Vaccine Potency, COVID-19, Plano São Paulo, Doria, João, Instituto Butantan, Coronavac, Sinovac Biotech

Coletiva de imprensa: anúncios do Governo SP - 23/10/2020

Date: 23/10/2020

O Governador João Doria confirmou a criação de seis novos centros de pesquisa científica para testagem e desenvolvimento da CoronaVac, que está em fase final dos estudos clínicos de segurança e eficácia contra o coronavírus. O anúncio foi feito nesta sexta-feira (23), durante entrevista coletiva no Palácio dos Bandeirantes. “A vacina, que é o tema do momento, é a proteção à vida ...
See more details

Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Coronavirus Infections/immunology, Coronavirus Infections/diagnosis, Pneumonia, Viral/epidemiology, Pneumonia, Viral/diagnosis, Pneumonia, Viral/immunology, Epidemiological Monitoring, Governmental Research Institutes, Pandemics/prevention & control, Local Health Systems/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Viral Vaccines/immunology, Quarantine/organization & administration, Clinical Trial, Phase III, Vaccine Potency, Healthy Volunteers, Plano São Paulo, Doria, João, COVID-19, Coronavac, Instituto Butantan, Sinovac Biotech, Instituto de Infectologia Emílio Ribas, Maia, Rodrigo

Coletiva de imprensa: anúncios do Governo SP - 26/10/2020

Date: 26/10/2020

O Governador João Doria anunciou nesta segunda-feira (26) o primeiro Mutirão de Qualificação, com a oferta de mais de 240 mil vagas em cursos gratuitos dos programas Via Rápida, Novotec, São Paulo Criativo, SP Tech e Empreenda Rápido. Os cursos virtuais, remotos e presenciais estarão disponíveis nos 645 municípios do estado. O anúncio faz parte do Retomada 21/22, plano anunciado dia 16 ...
See more details

Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Coronavirus Infections/diagnosis, Pneumonia, Viral/epidemiology, Pneumonia, Viral/diagnosis, Epidemiological Monitoring, Pandemics/prevention & control, Local Health Systems/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Quarantine/organization & administration, Credentialing, Masks, Social Isolation, Viral Vaccines/adverse effects, Healthy Volunteers, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Clinical Trial, Phase III, Viral Vaccines/supply & distribution, Plano São Paulo, Doria, João, COVID-19, Instituto Butantan, Coronavac, Sinovac Biotech

Ministério da Saúde atualiza informações sobre o combate à COVID-19 - 15.10.2020

Date: 15/10/2020

Siga o Ministério da Saúde http://www.twitter.com/minsaude http://www.facebook.com/minsaude http://www.instagram.com/minsaude https://www.linkedin.com/company/mini...
See more details

Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/statistics & numerical data, Intensive Care Units/statistics & numerical data, Hospital Bed Capacity/statistics & numerical data, Epidemiological Monitoring, Financial Resources in Health/economics, Ventilators, Mechanical/supply & distribution, Local Health Systems/organization & administration, Brazil/epidemiology, Coronavirus Infections/diagnosis, Schools, Primary Health Care/organization & administration, Personal Protective Equipment/supply & distribution, Chloroquine/supply & distribution, Hydroxychloroquine/supply & distribution, Oseltamivir/supply & distribution, Hypnotics and Sedatives/supply & distribution, Intubation, Drug Storage, Viral Vaccines/supply & distribution, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Clinical Trial, Phase III, Healthy Volunteers, Governmental Research Institutes, Academies and Institutes, COVID-19, Coronavac, Vacina de Oxford, Pfizer, Jassen, Astrazeneca, Sinovac Biotech, Instituto Butantan, Biontech, Wyeth, Covax

Coletiva de imprensa: anúncios do Governo SP - 30/09/2020

Date: 30/09/2020

O Governador João Doria assinou nesta quarta-feira (30) o termo de compromisso com a biofarmacêutica Sinovac Life Science para fornecimento de 46 milhões de doses da Coronavac ao estado de São Paulo até dezembro de 2020. O potencial imunizante contra o coronavírus é desenvolvido em parceria com o Instituto Butantan. “São Paulo não perde tempo, São Paulo quer proteger a saúde e a vida ...
See more details

Viral Vaccines/supply & distribution, Viral Vaccines/immunology, Pandemics/prevention & control, Clinical Trial, Phase III, Coronavirus Infections/immunology, Coronavirus Infections/epidemiology, Coronavirus Infections/prevention & control, Pneumonia, Viral/epidemiology, Pneumonia, Viral/prevention & control, Pneumonia, Viral/immunology, Epidemiological Monitoring, Governmental Research Institutes, Public-Private Sector Partnerships/organization & administration, Brazilian Health Surveillance Agency, Risk Groups, Vaccine Potency, Healthy Volunteers, Betacoronavirus/immunology, Local Health Systems/organization & administration, Pandemics/statistics & numerical data, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Social Isolation, Quarantine/organization & administration, Vulnerable Populations, Hospitals, Public/supply & distribution, Plano São Paulo, COVID-19, Doria, João, Coronavac, Instituto Butantan, Sinovac Biotech, Hospitais de camapnha

Coletiva de imprensa: anúncios do Governo SP - 28/09/2020

Date: 28/09/2020

O Governador João Doria anunciou nesta segunda-feira (28) que o estado de São Paulo completou 10 semanas consecutivas com diminuição de internações provocadas pelo coronavírus. Houve queda de 11% entre os dias 20 e 26 de setembro em relação à semana anterior, de 13 a 19 de setembro, de 1.266 para 1.125 na média estadual de hospitalizações. “A oscilação de internações é um indic...
See more details

Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/statistics & numerical data, Epidemiological Monitoring, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Local Health Systems/organization & administration, Quarantine/organization & administration, Social Isolation, Coronavirus Infections/transmission, Pneumonia, Viral/transmission, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/immunology, Clinical Trial, Phase III, Governmental Research Institutes, Viral Vaccines/adverse effects, Masks, Employment, COVID-19, Plano São Paulo, Doria, João, Instituto Butantan, Coronavac, Sinovac Biotech